We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+27.08%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$5.26B
AUM Growth
+$1.49B
Cap. Flow
+$577M
Cap. Flow %
10.98%
Top 10 Hldgs %
12.35%
Holding
400
New
51
Increased
150
Reduced
100
Closed
64

Top Buys

Rank Stock Value
1
BYND icon
Beyond Meat
BYND
+$34.6M
2
CNMD icon
CONMED
CNMD
+$17.5M
3
PRAH
PRA Health Sciences, Inc.
PRAH
+$15.6M
4
PZZA icon
Papa John's
PZZA
+$13.8M
5
RHP icon
Ryman Hospitality Properties
RHP
+$13.5M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$16.2M
2
TTD icon
Trade Desk
TTD
+$14M
3
SF
Stifel
SF
+$13.4M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$11.4M
5
MIDD icon
Middleby
MIDD
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Healthcare 18.43%
3 Financials 15.05%
4 Consumer Discretionary 13.49%
5 Industrials 11.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMP icon
226
Compass Minerals
CMP
$1.13B
$10.4M 0.2%
168,310
+70,219
+72% +$4.35M
PEB icon
227
Pebblebrook Hotel Trust
PEB
$2.01B
$10.4M 0.2%
+550,955
New +$8.92M
CHCT
228
Community Healthcare Trust
CHCT
$432M
$10.4M 0.2%
219,850
+69,712
+46% +$3.32M
CNX icon
229
CNX Resources
CNX
$5.35B
$10.2M 0.19%
945,257
+595,386
+170% +$6M
IONS icon
230
Ionis Pharmaceuticals
IONS
$9.21B
$10.1M 0.19%
178,304
+1,020
+0.6% +$50.8K
PACK icon
231
Ranpak Holdings
PACK
$461M
$9.98M 0.19%
742,580
+340,490
+85% +$3.75M
LBRT icon
232
Liberty Energy
LBRT
$3.51B
$9.89M 0.19%
959,751
+428,462
+81% +$3.91M
TBPH icon
233
Theravance Biopharma
TBPH
$878M
$9.81M 0.19%
551,830
+139,236
+34% +$2.5M
CUZ icon
234
Cousins Properties
CUZ
$4.83B
$9.77M 0.19%
291,693
+291,323
+78,736% +$9.01M
CERS icon
235
Cerus
CERS
$516M
$9.29M 0.18%
1,342,937
-230,835
-15% -$1.51M
ACAD icon
236
Acadia Pharmaceuticals
ACAD
$5.07B
$9.16M 0.17%
171,291
-16,798
-9% -$834K
VRRM icon
237
Verra Mobility
VRRM
$726M
$9.07M 0.17%
675,798
-61,015
-8% -$718K
ICHR icon
238
Ichor Holdings
ICHR
$2.53B
$9.06M 0.17%
+300,593
New +$8.5M
TRHC
239
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$8.46M 0.16%
197,416
-17,873
-8% -$678K
STRA icon
240
Strategic Education
STRA
$1.81B
$8.35M 0.16%
87,583
-51,790
-37% -$4.81M
PBH icon
241
Prestige Consumer Healthcare
PBH
$2.54B
$8.24M 0.16%
236,330
+99,597
+73% +$3.54M
ZYME icon
242
Zymeworks
ZYME
$1.73B
$7.96M 0.15%
168,338
-15,925
-9% -$740K
AVYA
243
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$7.77M 0.15%
+405,680
New +$7.54M
IMVT icon
244
Immunovant
IMVT
$8.45B
$7.6M 0.14%
164,617
-15,048
-8% -$696K
UVE icon
245
Universal Insurance Holdings
UVE
$1.19B
$7.34M 0.14%
485,569
+203,562
+72% +$2.87M
MNRL
246
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$7.27M 0.14%
661,231
+318,583
+93% +$3.29M
AOS icon
247
A.O. Smith
AOS
$8.65B
$7.09M 0.13%
129,382
-11,778
-8% -$649K
DK icon
248
Delek US
DK
$3.92B
$6.8M 0.13%
423,209
+176,084
+71% +$2.32M
BDTX icon
249
Black Diamond Therapeutics
BDTX
$120M
$6.73M 0.13%
209,911
+18,411
+10% +$605K
TLND
250
DELISTED
Talend S.A. American Depositary Shares
TLND
$6.57M 0.13%
171,456
-16,316
-9% -$642K
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Peregrine Capital Management held 400 positions worth $5.26B, up 39% from $3.77B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Peregrine Capital Management deployed $577M of net new capital in Q4 2020, opening 51 new positions and adding to 150 existing holdings. Its largest new stake was Beyond Meat: 229,246 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Trade Desk, an estimated $14M trimmed.

  • Peregrine Capital Management's largest Q4 2020 buy was Beyond Meat: 229,246 shares worth $28.7M.
  • Peregrine Capital Management added most to Splunk Inc in Q4 2020, an estimated $13.5M increase.
  • Peregrine Capital Management's biggest Q4 2020 reduction was Trade Desk, cutting an estimated $14M.
  • Peregrine Capital Management fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $16.2M.
  • Peregrine Capital Management's ten largest holdings make up 12% of its $5.26B portfolio in Q4 2020.
  • Peregrine Capital Management opened 51 new positions and closed 64 in Q4 2020.
  • Peregrine Capital Management's portfolio value rose 39% quarter-over-quarter to $5.26B.

Based on Peregrine Capital Management's 13F filing for Q4 2020, filed 19 Jan 2021.